Arthur Higgins has changed board positions at Assertio Therapeutics, Inc.
Jun 29, 2020
Board and Executive Moves
Senior Advisor at The Blackstone Group, Inc.
In The News
Dec 15, 2020 - GlobeNewswire
Jun 29, 2020 - RelSci
Assertio Completed Merger with Zyla Life Sciences; Trading under ASRT on Nasdaq Global Select Market
May 20, 2020 - PR Newswire
Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.
In The News
Migraine Pipeline Review, H2 2020 - Therapeutic Assessment of 73 Companies & Respective Drug Profiles - ResearchAndMarkets.com
Dec 31, 2020 - Business Wire
Migraine Pipeline Review, H2 2020: Therapeutics Development & Assessment, Drug Profiles, Dormant Projects, Discontinued Products, Development Milestones, Competitive Landscape
Dec 23, 2020 - GlobeNewswire
Nov 06, 2020 - SEC